How to design the surface of peptide-loaded nanoparticles for efficient oral bioavailability?

被引:84
作者
Malhaire, Helene [1 ,2 ]
Gimel, Jean-Christophe [1 ,2 ]
Roger, Emilie [1 ,2 ]
Benoit, Jean-Pierre [1 ,2 ]
Lagarce, Frederic [1 ,2 ,3 ]
机构
[1] INSERM U1066 Micro & Nanomed Biomimet, Angers, France
[2] Univ Angers, Angers, France
[3] Angers Univ Hosp, Dept Pharm, Angers, France
关键词
Protein and peptide drugs; Nanoparticle; Specific surface area; Protein corona; Mucus interaction; SOLID LIPID NANOPARTICLES; WHEAT-GERM-AGGLUTININ; INSULIN DELIVERY-SYSTEMS; HUMAN CERVICAL-MUCUS; IN-VIVO EVALUATION; MEDIATED DRUG-DELIVERY; WATER-SOLUBLE DRUG; INTESTINAL-ABSORPTION; P-GLYCOPROTEIN; MUCOADHESIVE POLYMERS;
D O I
10.1016/j.addr.2016.03.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The oral administration of proteins is a current challenge to be faced in the field of therapeutics. There is currently much interest in nanocarriers since they can enhance oral bioavailability. For lack of a clear definition, the key characteristics of nanoparticles have been highlighted. Specific surface area is one of these characteristics and represents a huge source of energy that can be used to control the biological fate of the carrier. The review discusses nanocarrier stability, mucus interaction and absorption through the intestinal epithelium. The protein corona, which has raised interest over the last decade, is also discussed. The universal ideal surface is a myth and over-coated carriers are not a solution either. Besides, common excipients can be useful on several targets. The suitable design should rather take into account the composition, structure and behavior of unmodified nanomaterials. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:320 / 336
页数:17
相关论文
共 264 条
[1]   Exposure Assessment Approaches for Engineered Nanomaterials [J].
Abbott, Linda C. ;
Maynard, Andrew D. .
RISK ANALYSIS, 2010, 30 (11) :1634-1644
[2]   Nanoparticle diffusion within intestinal mucus: Three-dimensional response analysis dissecting the impact of particle surface charge, size and heterogeneity across polyelectrolyte, pegylated and viral particles [J].
Abdulkarim, Muthanna ;
Agullo, Nuria ;
Cattoz, Beatrice ;
Griffiths, Peter ;
Bernkop-Schnuerch, Andreas ;
Gomez Borros, Salvador ;
Gumbleton, Mark .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 97 :230-238
[3]   Role of breast cancer resistance protein (Bcrp1/Abcg2) in the extrusion of glucuronide and sulfate conjugates from enterocytes to intestinal lumen [J].
Adachi, Y ;
Suzuki, H ;
Schinkel, AH ;
Sugiyama, Y .
MOLECULAR PHARMACOLOGY, 2005, 67 (03) :923-928
[4]  
Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]
[5]  
ALBANESE CT, 1994, SURGERY, V116, P76
[6]   Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics [J].
Allémann, E ;
Leroux, JC ;
Gurny, R .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 34 (2-3) :171-189
[7]   Papain, a plant enzyme of biological importance: A review [J].
Amri, Ezekiel ;
Mamboya, Florence .
American Journal of Biochemistry and Biotechnology, 2012, 8 (02) :99-104
[8]   Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: Interactions with mucin and biomembrane models [J].
Andreani, Tatiana ;
Miziara, Leonardo ;
Lorenzon, Esteban N. ;
de Souza, Ana Luiza R. ;
Kiill, Charlene P. ;
Fangueiro, Joana F. ;
Garcia, Maria L. ;
Gremiao, Palmira D. ;
Silva, Amelia M. ;
Souto, Eliana B. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 93 :118-126
[9]   Preparation and characterization of PEG-coated silica nanoparticles for oral insulin delivery [J].
Andreani, Tatiana ;
de Souza, Ana Luiza R. ;
Kiill, Charlene P. ;
Lorenzon, Esteban N. ;
Fangueiro, Joana F. ;
Cristina Calpena, Ana ;
Chaud, Marco V. ;
Garcia, Maria L. ;
Gremiao, Maria Palmira D. ;
Silva, Amelia M. ;
Souto, Eliana B. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 473 (1-2) :627-635
[10]   Mucoadhesive polymeric platforms for controlled drug delivery [J].
Andrews, Gavin P. ;
Laverty, Thomas P. ;
Jones, David S. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2009, 71 (03) :505-518